| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| IL-21 | HOTDMF GMP-L21H15 | GMP Human IL-21 Protein (E. coli) | Human | E. coli | ![]() | MSSDS-PAGE | $1020.00 50ug | ||
| IL-21 | HOTDMF GMP-L21H25 | GMP Human IL-21 Protein | Human | HEK293 | ![]() | SDS-PAGE | $1020.00 50ug | ||
| IL-21 | HOT IL1-H5253 | Human IL-21 Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | ||
| IL-21 | HOT IL1-H5213 | Human IL-21 Protein, premium grade | Human | HEK293 | ![]() | HPLCSDS-PAGE | $235.00 20ug | ||
| IL-21 | HOTAvitag IL1-H82F7 | Biotinylated Human IL-21 Protein, Fc,Avitag™, premium grade | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| IL-21 | Cynomolgus IL-21 Protein, Fc Tag (MALS & SPR verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $360.00 100ug | |||
| IL-21 | Cynomolgus IL-21 Protein, His Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | |||
| IL-21 | Human IL-21 Superior Stable Mutant Protein, premium grade | Human | E. coli | HPLCSDS-PAGE | $345.00 20ug | ||||
| IL-21 | Human IL-21 Protein (E. coli), premium grade | Human | E. coli | ![]() | HPLCSDS-PAGE | $230.00 20ug | |||
| IL-21 | Human IL-21 Protein (E. coli), Research Grade | Human | E. coli | ![]() | HPLCSDS-PAGE | $198.00 20ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| CVD-1301.V01 | hV-01; CVD-1301.V01; V 01 | Phase 2 Clinical | Hangzhou Converd Co Ltd | Pancreatic Neoplasms; Sarcoma 180; Solid tumours; Uterine Cervical Neoplasms | Details |
| IL-21 mab (Lilly) | Phase 1 Clinical | Eli Lilly And Company | Immune System Diseases | Details | |
| triple anti-CD19 CAR T-cell therapy/PD-1 checkpoint inhibitor/IL-21 receptor agonist (CD (Suzhou) Biopharma/Chinese People's Liberation Army General Hospital/Chinese academy of sciences) | Phase 1 Clinical | Chinese Academy Of Sciences | Hematologic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Details | |
| CD-001 | CD-001 | Phase 1 Clinical | CD (Suzhou) Biopharma Co Ltd | Head and Neck Neoplasms; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Solid tumours | Details |